Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Trial Identifier: D7460C00004
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT06406400
Start Date: May 2024
Primary Completion Date: May 2026
Study Completion Date: May 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, MD Baltimore, MD, US, 21225